Al's Comment:

 We had high expectations for this treatment, and were shocked when it failed the clinical trial.  this article may explain why and opens the door to try again using a way to get the treatment into the brain - perhaps with focused ultrasound, or other ways around the blood brain barrier.


Posted on: 06/04/2021

Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma


Click HERE to return to brain tumor news headlines.